ClinicalTrials.Veeva

Menu

Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome

C

CHU Brugmann University Hospital

Status

Enrolling

Conditions

Complex Regional Pain Syndromes

Treatments

Drug: Capsaïcine patch

Study type

Observational

Funder types

Other

Identifiers

NCT05523934
patch_CRPS-retro

Details and patient eligibility

About

Complex regional pain syndrome is a painful syndrome often secondary to a traumatic lesion. Treatment is difficult, of long duration with variable outcomes. Patch of capsaïcin has been proposed as adjuvant to a multimodal treatment. Capsaïcin may act by its effect on transient receptor potential vanilloid 1. Efficacity and outcome studies with this treatment are lacking.

The aim of this retrospective study is to evaluate pain intensity over time assessed by visual analog scale in patient with complex regional pain syndrome treated with capsaïcin patch in addition to their usual treatment.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients with complex regional pain syndrome on maximum medical treatment
  • Age ≥18 years
  • Patients treated between 2012 and August 31, 2022 in the pain clinic of the CHU Brugmann

Exclusion criteria

  • incomplete medical chart

Trial contacts and locations

1

Loading...

Central trial contact

Denis Schmartz, MD; Charlie Reynaud, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems